Table 1 Demographic and clinical characteristics of NMOSD patients and healthy controls
From: Intravitreal delivery of NMO-IgG causes primary retinal damage in the absence of optic nerve injury
| Â | Age (years) | Sex (M/F) | AQP4-IgG titer | MOG-IgG titer | Disease duration (months) | |
|---|---|---|---|---|---|---|
CSF | Plasma | Plasma | ||||
Patient 1 | 52 | F | 1:3.2 | 1:1000 | – | 11 |
Patient 2 | 31 | F | 1:1 | 1:1000 | – | 20 |
Patient 3 | 50 | F | – | 1:1000 | – | 3 |
Patient 4 | 45 | F | 1:3.2 | 1:1000 | – | 9 |
Control 1 | 42 | M | – | – | – | – |
Control 2 | 42 | F | – | – | – | – |
Control 3 | 31 | F | – | – | – | – |
Control 4 | 40 | F | – | – | – | – |